nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—ABCC10—Estradiol—osteoporosis	0.0761	0.131	CbGbCtD
Doxorubicin—ABCB11—Ethinyl Estradiol—osteoporosis	0.0642	0.11	CbGbCtD
Doxorubicin—ABCC1—Zoledronate—osteoporosis	0.0602	0.103	CbGbCtD
Doxorubicin—ABCC3—Conjugated Estrogens—osteoporosis	0.0545	0.0936	CbGbCtD
Doxorubicin—CYP1B1—Estradiol—osteoporosis	0.0414	0.071	CbGbCtD
Doxorubicin—ABCC2—Ethinyl Estradiol—osteoporosis	0.0338	0.058	CbGbCtD
Doxorubicin—ABCC1—Conjugated Estrogens—osteoporosis	0.0335	0.0575	CbGbCtD
Doxorubicin—ABCC2—Conjugated Estrogens—osteoporosis	0.0248	0.0425	CbGbCtD
Doxorubicin—ABCG2—Conjugated Estrogens—osteoporosis	0.0224	0.0385	CbGbCtD
Doxorubicin—CYP2B6—Raloxifene—osteoporosis	0.0222	0.0382	CbGbCtD
Doxorubicin—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0215	0.0369	CbGbCtD
Doxorubicin—ABCG2—Estradiol—osteoporosis	0.0197	0.0338	CbGbCtD
Doxorubicin—CYP2B6—Cholecalciferol—osteoporosis	0.0172	0.0295	CbGbCtD
Doxorubicin—ABCB1—Ethinyl Estradiol—osteoporosis	0.011	0.0189	CbGbCtD
Doxorubicin—CYP3A4—Calcitriol—osteoporosis	0.0102	0.0176	CbGbCtD
Doxorubicin—CYP3A4—Estropipate—osteoporosis	0.0102	0.0176	CbGbCtD
Doxorubicin—CYP2D6—Cholecalciferol—osteoporosis	0.00829	0.0142	CbGbCtD
Doxorubicin—CYP3A4—Ergocalciferol—osteoporosis	0.00818	0.014	CbGbCtD
Doxorubicin—ABCB1—Conjugated Estrogens—osteoporosis	0.00808	0.0139	CbGbCtD
Doxorubicin—ABCB1—Estradiol—osteoporosis	0.00709	0.0122	CbGbCtD
Doxorubicin—CYP3A4—Raloxifene—osteoporosis	0.00683	0.0117	CbGbCtD
Doxorubicin—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0066	0.0113	CbGbCtD
Doxorubicin—CYP3A4—Cholecalciferol—osteoporosis	0.00527	0.00905	CbGbCtD
Doxorubicin—CYP3A4—Conjugated Estrogens—osteoporosis	0.00484	0.00831	CbGbCtD
Doxorubicin—CYP3A4—Estradiol—osteoporosis	0.00425	0.0073	CbGbCtD
Doxorubicin—SLC22A16—bone marrow—osteoporosis	0.00167	0.0866	CbGeAlD
Doxorubicin—AKR1A1—uterus—osteoporosis	0.00114	0.059	CbGeAlD
Doxorubicin—AKR1A1—bone marrow—osteoporosis	0.000964	0.0501	CbGeAlD
Doxorubicin—AURKA—uterus—osteoporosis	0.000959	0.0498	CbGeAlD
Doxorubicin—NDUFS7—bone marrow—osteoporosis	0.000876	0.0455	CbGeAlD
Doxorubicin—NDUFS2—uterus—osteoporosis	0.000855	0.0444	CbGeAlD
Doxorubicin—NDUFS3—uterus—osteoporosis	0.000845	0.0439	CbGeAlD
Doxorubicin—AURKA—bone marrow—osteoporosis	0.000814	0.0423	CbGeAlD
Doxorubicin—CBR3—Estradiol valerate/Dienogest—Estradiol—osteoporosis	0.000752	0.179	CbGdCrCtD
Doxorubicin—YWHAG—uterus—osteoporosis	0.000736	0.0382	CbGeAlD
Doxorubicin—CBR3—Estradiol valerate/Dienogest—Ethinyl Estradiol—osteoporosis	0.000734	0.174	CbGdCrCtD
Doxorubicin—NDUFS2—bone marrow—osteoporosis	0.000726	0.0377	CbGeAlD
Doxorubicin—NDUFS3—bone marrow—osteoporosis	0.000717	0.0372	CbGeAlD
Doxorubicin—DHCR7—bone marrow—osteoporosis	0.000681	0.0354	CbGeAlD
Doxorubicin—RALBP1—uterus—osteoporosis	0.000665	0.0345	CbGeAlD
Doxorubicin—AURKA—Calcipotriol—Ergocalciferol—osteoporosis	0.00064	0.152	CbGdCrCtD
Doxorubicin—AURKA—Calcipotriol—Calcitriol—osteoporosis	0.00064	0.152	CbGdCrCtD
Doxorubicin—YWHAG—bone marrow—osteoporosis	0.000625	0.0325	CbGeAlD
Doxorubicin—CBR1—uterus—osteoporosis	0.000621	0.0322	CbGeAlD
Doxorubicin—AKR1C3—uterus—osteoporosis	0.000613	0.0318	CbGeAlD
Doxorubicin—RALBP1—bone marrow—osteoporosis	0.000564	0.0293	CbGeAlD
Doxorubicin—AURKA—Calcipotriol—Cholecalciferol—osteoporosis	0.000544	0.129	CbGdCrCtD
Doxorubicin—CBR1—bone marrow—osteoporosis	0.000527	0.0274	CbGeAlD
Doxorubicin—TOP2A—uterus—osteoporosis	0.000522	0.0271	CbGeAlD
Doxorubicin—AKR1C3—bone marrow—osteoporosis	0.00052	0.027	CbGeAlD
Doxorubicin—NQO1—uterus—osteoporosis	0.000497	0.0258	CbGeAlD
Doxorubicin—POR—bone marrow—osteoporosis	0.000475	0.0247	CbGeAlD
Doxorubicin—ABCC10—uterus—osteoporosis	0.000444	0.0231	CbGeAlD
Doxorubicin—TOP2A—bone marrow—osteoporosis	0.000443	0.023	CbGeAlD
Doxorubicin—AURKA—Fulvestrant—Estradiol—osteoporosis	0.000423	0.1	CbGdCrCtD
Doxorubicin—ABCC10—bone marrow—osteoporosis	0.000377	0.0196	CbGeAlD
Doxorubicin—CYP1B1—uterus—osteoporosis	0.000349	0.0181	CbGeAlD
Doxorubicin—ABCC1—uterus—osteoporosis	0.000314	0.0163	CbGeAlD
Doxorubicin—ABCG2—uterus—osteoporosis	0.00026	0.0135	CbGeAlD
Doxorubicin—ABCG2—bone marrow—osteoporosis	0.000221	0.0115	CbGeAlD
Doxorubicin—TOP2A—Fulvestrant—Estradiol—osteoporosis	0.000162	0.0384	CbGdCrCtD
Doxorubicin—ABCB1—uterus—osteoporosis	0.000128	0.00666	CbGeAlD
Doxorubicin—ABCB1—bone marrow—osteoporosis	0.000109	0.00565	CbGeAlD
Doxorubicin—TOP2A—Levorphanol—Estradiol—osteoporosis	0.000107	0.0253	CbGdCrCtD
Doxorubicin—TOP2A—Methyltestosterone—Ethinyl Estradiol—osteoporosis	9.75e-05	0.0231	CbGdCrCtD
Doxorubicin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	8.03e-05	0.000314	CcSEcCtD
Doxorubicin—Fatigue—Ethinyl Estradiol—osteoporosis	8.02e-05	0.000313	CcSEcCtD
Doxorubicin—Pruritus—Alendronate—osteoporosis	7.99e-05	0.000312	CcSEcCtD
Doxorubicin—Dyspepsia—Risedronate—osteoporosis	7.98e-05	0.000312	CcSEcCtD
Doxorubicin—Eye disorder—Estradiol—osteoporosis	7.98e-05	0.000312	CcSEcCtD
Doxorubicin—Tinnitus—Estradiol—osteoporosis	7.96e-05	0.000311	CcSEcCtD
Doxorubicin—Constipation—Ethinyl Estradiol—osteoporosis	7.95e-05	0.000311	CcSEcCtD
Doxorubicin—Confusional state—Zoledronate—osteoporosis	7.94e-05	0.00031	CcSEcCtD
Doxorubicin—Hypersensitivity—Calcitriol—osteoporosis	7.93e-05	0.00031	CcSEcCtD
Doxorubicin—Flushing—Estradiol—osteoporosis	7.92e-05	0.00031	CcSEcCtD
Doxorubicin—Cardiac disorder—Estradiol—osteoporosis	7.92e-05	0.00031	CcSEcCtD
Doxorubicin—Chest pain—Conjugated Estrogens—osteoporosis	7.91e-05	0.000309	CcSEcCtD
Doxorubicin—Myalgia—Conjugated Estrogens—osteoporosis	7.91e-05	0.000309	CcSEcCtD
Doxorubicin—Arthralgia—Conjugated Estrogens—osteoporosis	7.91e-05	0.000309	CcSEcCtD
Doxorubicin—Asthenia—Ibandronate—osteoporosis	7.89e-05	0.000308	CcSEcCtD
Doxorubicin—Anxiety—Conjugated Estrogens—osteoporosis	7.88e-05	0.000308	CcSEcCtD
Doxorubicin—Nausea—Etidronic acid—osteoporosis	7.88e-05	0.000308	CcSEcCtD
Doxorubicin—Oedema—Zoledronate—osteoporosis	7.87e-05	0.000308	CcSEcCtD
Doxorubicin—Anaphylactic shock—Zoledronate—osteoporosis	7.87e-05	0.000308	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	7.85e-05	0.000307	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Pamidronate—osteoporosis	7.85e-05	0.000307	CcSEcCtD
Doxorubicin—Diarrhoea—Estropipate—osteoporosis	7.85e-05	0.000307	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Risedronate—osteoporosis	7.83e-05	0.000306	CcSEcCtD
Doxorubicin—Infection—Zoledronate—osteoporosis	7.82e-05	0.000306	CcSEcCtD
Doxorubicin—Fatigue—Risedronate—osteoporosis	7.82e-05	0.000305	CcSEcCtD
Doxorubicin—Insomnia—Pamidronate—osteoporosis	7.79e-05	0.000305	CcSEcCtD
Doxorubicin—Pruritus—Ibandronate—osteoporosis	7.78e-05	0.000304	CcSEcCtD
Doxorubicin—Pain—Risedronate—osteoporosis	7.75e-05	0.000303	CcSEcCtD
Doxorubicin—Constipation—Risedronate—osteoporosis	7.75e-05	0.000303	CcSEcCtD
Doxorubicin—Angiopathy—Estradiol—osteoporosis	7.75e-05	0.000303	CcSEcCtD
Doxorubicin—Shock—Zoledronate—osteoporosis	7.74e-05	0.000303	CcSEcCtD
Doxorubicin—Paraesthesia—Pamidronate—osteoporosis	7.74e-05	0.000302	CcSEcCtD
Doxorubicin—Diarrhoea—Alendronate—osteoporosis	7.73e-05	0.000302	CcSEcCtD
Doxorubicin—Asthenia—Calcitriol—osteoporosis	7.73e-05	0.000302	CcSEcCtD
Doxorubicin—Nervous system disorder—Zoledronate—osteoporosis	7.72e-05	0.000302	CcSEcCtD
Doxorubicin—Immune system disorder—Estradiol—osteoporosis	7.71e-05	0.000301	CcSEcCtD
Doxorubicin—Thrombocytopenia—Zoledronate—osteoporosis	7.71e-05	0.000301	CcSEcCtD
Doxorubicin—Mediastinal disorder—Estradiol—osteoporosis	7.7e-05	0.000301	CcSEcCtD
Doxorubicin—Dyspnoea—Pamidronate—osteoporosis	7.68e-05	0.0003	CcSEcCtD
Doxorubicin—Tachycardia—Zoledronate—osteoporosis	7.68e-05	0.0003	CcSEcCtD
Doxorubicin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	7.66e-05	0.000299	CcSEcCtD
Doxorubicin—Chills—Estradiol—osteoporosis	7.66e-05	0.000299	CcSEcCtD
Doxorubicin—Somnolence—Pamidronate—osteoporosis	7.66e-05	0.000299	CcSEcCtD
Doxorubicin—Skin disorder—Zoledronate—osteoporosis	7.65e-05	0.000299	CcSEcCtD
Doxorubicin—Pruritus—Calcitriol—osteoporosis	7.62e-05	0.000298	CcSEcCtD
Doxorubicin—Hyperhidrosis—Zoledronate—osteoporosis	7.61e-05	0.000297	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	7.6e-05	0.000297	CcSEcCtD
Doxorubicin—Diarrhoea—Raloxifene—osteoporosis	7.6e-05	0.000297	CcSEcCtD
Doxorubicin—Dyspepsia—Pamidronate—osteoporosis	7.59e-05	0.000296	CcSEcCtD
Doxorubicin—Dizziness—Estropipate—osteoporosis	7.59e-05	0.000296	CcSEcCtD
Doxorubicin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	7.58e-05	0.000296	CcSEcCtD
Doxorubicin—Oedema—Conjugated Estrogens—osteoporosis	7.58e-05	0.000296	CcSEcCtD
Doxorubicin—Alopecia—Estradiol—osteoporosis	7.55e-05	0.000295	CcSEcCtD
Doxorubicin—Infection—Conjugated Estrogens—osteoporosis	7.53e-05	0.000294	CcSEcCtD
Doxorubicin—Diarrhoea—Ibandronate—osteoporosis	7.53e-05	0.000294	CcSEcCtD
Doxorubicin—Anorexia—Zoledronate—osteoporosis	7.5e-05	0.000293	CcSEcCtD
Doxorubicin—Decreased appetite—Pamidronate—osteoporosis	7.49e-05	0.000293	CcSEcCtD
Doxorubicin—Mental disorder—Estradiol—osteoporosis	7.48e-05	0.000292	CcSEcCtD
Doxorubicin—Dizziness—Alendronate—osteoporosis	7.47e-05	0.000292	CcSEcCtD
Doxorubicin—Shock—Conjugated Estrogens—osteoporosis	7.46e-05	0.000291	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Pamidronate—osteoporosis	7.44e-05	0.000291	CcSEcCtD
Doxorubicin—Nervous system disorder—Conjugated Estrogens—osteoporosis	7.43e-05	0.00029	CcSEcCtD
Doxorubicin—Erythema—Estradiol—osteoporosis	7.43e-05	0.00029	CcSEcCtD
Doxorubicin—Malnutrition—Estradiol—osteoporosis	7.43e-05	0.00029	CcSEcCtD
Doxorubicin—Fatigue—Pamidronate—osteoporosis	7.43e-05	0.00029	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Risedronate—osteoporosis	7.41e-05	0.00029	CcSEcCtD
Doxorubicin—Tachycardia—Conjugated Estrogens—osteoporosis	7.4e-05	0.000289	CcSEcCtD
Doxorubicin—Urticaria—Ethinyl Estradiol—osteoporosis	7.39e-05	0.000289	CcSEcCtD
Doxorubicin—Constipation—Pamidronate—osteoporosis	7.37e-05	0.000288	CcSEcCtD
Doxorubicin—Pain—Pamidronate—osteoporosis	7.37e-05	0.000288	CcSEcCtD
Doxorubicin—Diarrhoea—Calcitriol—osteoporosis	7.37e-05	0.000288	CcSEcCtD
Doxorubicin—Skin disorder—Conjugated Estrogens—osteoporosis	7.36e-05	0.000288	CcSEcCtD
Doxorubicin—Hypotension—Zoledronate—osteoporosis	7.36e-05	0.000287	CcSEcCtD
Doxorubicin—Body temperature increased—Ethinyl Estradiol—osteoporosis	7.35e-05	0.000287	CcSEcCtD
Doxorubicin—Abdominal pain—Ethinyl Estradiol—osteoporosis	7.35e-05	0.000287	CcSEcCtD
Doxorubicin—Dizziness—Raloxifene—osteoporosis	7.35e-05	0.000287	CcSEcCtD
Doxorubicin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	7.33e-05	0.000286	CcSEcCtD
Doxorubicin—Flatulence—Estradiol—osteoporosis	7.32e-05	0.000286	CcSEcCtD
Doxorubicin—Tension—Estradiol—osteoporosis	7.29e-05	0.000285	CcSEcCtD
Doxorubicin—Vomiting—Estropipate—osteoporosis	7.29e-05	0.000285	CcSEcCtD
Doxorubicin—Dysgeusia—Estradiol—osteoporosis	7.28e-05	0.000284	CcSEcCtD
Doxorubicin—Dizziness—Ibandronate—osteoporosis	7.27e-05	0.000284	CcSEcCtD
Doxorubicin—Rash—Estropipate—osteoporosis	7.23e-05	0.000283	CcSEcCtD
Doxorubicin—Dermatitis—Estropipate—osteoporosis	7.23e-05	0.000282	CcSEcCtD
Doxorubicin—Anorexia—Conjugated Estrogens—osteoporosis	7.23e-05	0.000282	CcSEcCtD
Doxorubicin—Nervousness—Estradiol—osteoporosis	7.22e-05	0.000282	CcSEcCtD
Doxorubicin—Urticaria—Risedronate—osteoporosis	7.2e-05	0.000281	CcSEcCtD
Doxorubicin—Back pain—Estradiol—osteoporosis	7.19e-05	0.000281	CcSEcCtD
Doxorubicin—Headache—Estropipate—osteoporosis	7.19e-05	0.000281	CcSEcCtD
Doxorubicin—Vomiting—Alendronate—osteoporosis	7.18e-05	0.000281	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Zoledronate—osteoporosis	7.17e-05	0.00028	CcSEcCtD
Doxorubicin—Abdominal pain—Risedronate—osteoporosis	7.17e-05	0.00028	CcSEcCtD
Doxorubicin—Body temperature increased—Risedronate—osteoporosis	7.17e-05	0.00028	CcSEcCtD
Doxorubicin—Muscle spasms—Estradiol—osteoporosis	7.15e-05	0.000279	CcSEcCtD
Doxorubicin—Rash—Alendronate—osteoporosis	7.12e-05	0.000278	CcSEcCtD
Doxorubicin—Insomnia—Zoledronate—osteoporosis	7.12e-05	0.000278	CcSEcCtD
Doxorubicin—Dermatitis—Alendronate—osteoporosis	7.12e-05	0.000278	CcSEcCtD
Doxorubicin—Feeling abnormal—Pamidronate—osteoporosis	7.1e-05	0.000278	CcSEcCtD
Doxorubicin—Hypotension—Conjugated Estrogens—osteoporosis	7.08e-05	0.000277	CcSEcCtD
Doxorubicin—Headache—Alendronate—osteoporosis	7.08e-05	0.000277	CcSEcCtD
Doxorubicin—Paraesthesia—Zoledronate—osteoporosis	7.07e-05	0.000276	CcSEcCtD
Doxorubicin—Vomiting—Raloxifene—osteoporosis	7.07e-05	0.000276	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Pamidronate—osteoporosis	7.05e-05	0.000275	CcSEcCtD
Doxorubicin—Dyspnoea—Zoledronate—osteoporosis	7.02e-05	0.000274	CcSEcCtD
Doxorubicin—Rash—Raloxifene—osteoporosis	7.01e-05	0.000274	CcSEcCtD
Doxorubicin—Dermatitis—Raloxifene—osteoporosis	7e-05	0.000274	CcSEcCtD
Doxorubicin—Somnolence—Zoledronate—osteoporosis	7e-05	0.000273	CcSEcCtD
Doxorubicin—Vomiting—Ibandronate—osteoporosis	6.99e-05	0.000273	CcSEcCtD
Doxorubicin—Headache—Raloxifene—osteoporosis	6.96e-05	0.000272	CcSEcCtD
Doxorubicin—Rash—Ibandronate—osteoporosis	6.94e-05	0.000271	CcSEcCtD
Doxorubicin—Dermatitis—Ibandronate—osteoporosis	6.93e-05	0.000271	CcSEcCtD
Doxorubicin—Dyspepsia—Zoledronate—osteoporosis	6.93e-05	0.000271	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	6.91e-05	0.00027	CcSEcCtD
Doxorubicin—Ill-defined disorder—Estradiol—osteoporosis	6.9e-05	0.00027	CcSEcCtD
Doxorubicin—Headache—Ibandronate—osteoporosis	6.89e-05	0.000269	CcSEcCtD
Doxorubicin—Insomnia—Conjugated Estrogens—osteoporosis	6.86e-05	0.000268	CcSEcCtD
Doxorubicin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	6.85e-05	0.000268	CcSEcCtD
Doxorubicin—Vomiting—Calcitriol—osteoporosis	6.85e-05	0.000268	CcSEcCtD
Doxorubicin—Decreased appetite—Zoledronate—osteoporosis	6.84e-05	0.000267	CcSEcCtD
Doxorubicin—Agitation—Estradiol—osteoporosis	6.83e-05	0.000267	CcSEcCtD
Doxorubicin—Nausea—Estropipate—osteoporosis	6.81e-05	0.000266	CcSEcCtD
Doxorubicin—Abdominal pain—Pamidronate—osteoporosis	6.81e-05	0.000266	CcSEcCtD
Doxorubicin—Body temperature increased—Pamidronate—osteoporosis	6.81e-05	0.000266	CcSEcCtD
Doxorubicin—Paraesthesia—Conjugated Estrogens—osteoporosis	6.81e-05	0.000266	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Zoledronate—osteoporosis	6.8e-05	0.000266	CcSEcCtD
Doxorubicin—Rash—Calcitriol—osteoporosis	6.79e-05	0.000265	CcSEcCtD
Doxorubicin—Fatigue—Zoledronate—osteoporosis	6.79e-05	0.000265	CcSEcCtD
Doxorubicin—Dermatitis—Calcitriol—osteoporosis	6.78e-05	0.000265	CcSEcCtD
Doxorubicin—Dyspnoea—Conjugated Estrogens—osteoporosis	6.76e-05	0.000264	CcSEcCtD
Doxorubicin—Headache—Calcitriol—osteoporosis	6.75e-05	0.000264	CcSEcCtD
Doxorubicin—Somnolence—Conjugated Estrogens—osteoporosis	6.74e-05	0.000263	CcSEcCtD
Doxorubicin—Constipation—Zoledronate—osteoporosis	6.73e-05	0.000263	CcSEcCtD
Doxorubicin—Pain—Zoledronate—osteoporosis	6.73e-05	0.000263	CcSEcCtD
Doxorubicin—Nausea—Alendronate—osteoporosis	6.71e-05	0.000262	CcSEcCtD
Doxorubicin—Malaise—Estradiol—osteoporosis	6.7e-05	0.000262	CcSEcCtD
Doxorubicin—Hypersensitivity—Risedronate—osteoporosis	6.68e-05	0.000261	CcSEcCtD
Doxorubicin—Vertigo—Estradiol—osteoporosis	6.68e-05	0.000261	CcSEcCtD
Doxorubicin—Dyspepsia—Conjugated Estrogens—osteoporosis	6.67e-05	0.000261	CcSEcCtD
Doxorubicin—Asthenia—Ethinyl Estradiol—osteoporosis	6.67e-05	0.000261	CcSEcCtD
Doxorubicin—Syncope—Estradiol—osteoporosis	6.67e-05	0.00026	CcSEcCtD
Doxorubicin—Nausea—Raloxifene—osteoporosis	6.6e-05	0.000258	CcSEcCtD
Doxorubicin—Decreased appetite—Conjugated Estrogens—osteoporosis	6.59e-05	0.000257	CcSEcCtD
Doxorubicin—Pruritus—Ethinyl Estradiol—osteoporosis	6.58e-05	0.000257	CcSEcCtD
Doxorubicin—Palpitations—Estradiol—osteoporosis	6.57e-05	0.000257	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	6.54e-05	0.000256	CcSEcCtD
Doxorubicin—Fatigue—Conjugated Estrogens—osteoporosis	6.54e-05	0.000255	CcSEcCtD
Doxorubicin—Nausea—Ibandronate—osteoporosis	6.53e-05	0.000255	CcSEcCtD
Doxorubicin—Loss of consciousness—Estradiol—osteoporosis	6.53e-05	0.000255	CcSEcCtD
Doxorubicin—Asthenia—Risedronate—osteoporosis	6.5e-05	0.000254	CcSEcCtD
Doxorubicin—Feeling abnormal—Zoledronate—osteoporosis	6.49e-05	0.000254	CcSEcCtD
Doxorubicin—Cough—Estradiol—osteoporosis	6.49e-05	0.000253	CcSEcCtD
Doxorubicin—Constipation—Conjugated Estrogens—osteoporosis	6.48e-05	0.000253	CcSEcCtD
Doxorubicin—Pain—Conjugated Estrogens—osteoporosis	6.48e-05	0.000253	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Zoledronate—osteoporosis	6.44e-05	0.000252	CcSEcCtD
Doxorubicin—Hypertension—Estradiol—osteoporosis	6.42e-05	0.000251	CcSEcCtD
Doxorubicin—Pruritus—Risedronate—osteoporosis	6.41e-05	0.000251	CcSEcCtD
Doxorubicin—Nausea—Calcitriol—osteoporosis	6.4e-05	0.00025	CcSEcCtD
Doxorubicin—Diarrhoea—Ethinyl Estradiol—osteoporosis	6.36e-05	0.000249	CcSEcCtD
Doxorubicin—TOP2A—Norethindrone—Ethinyl Estradiol—osteoporosis	6.36e-05	0.0151	CbGdCrCtD
Doxorubicin—Hypersensitivity—Pamidronate—osteoporosis	6.35e-05	0.000248	CcSEcCtD
Doxorubicin—Myalgia—Estradiol—osteoporosis	6.33e-05	0.000247	CcSEcCtD
Doxorubicin—Arthralgia—Estradiol—osteoporosis	6.33e-05	0.000247	CcSEcCtD
Doxorubicin—Chest pain—Estradiol—osteoporosis	6.33e-05	0.000247	CcSEcCtD
Doxorubicin—Anxiety—Estradiol—osteoporosis	6.31e-05	0.000246	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	6.28e-05	0.000246	CcSEcCtD
Doxorubicin—Urticaria—Zoledronate—osteoporosis	6.25e-05	0.000244	CcSEcCtD
Doxorubicin—Discomfort—Estradiol—osteoporosis	6.25e-05	0.000244	CcSEcCtD
Doxorubicin—Abdominal pain—Zoledronate—osteoporosis	6.22e-05	0.000243	CcSEcCtD
Doxorubicin—Body temperature increased—Zoledronate—osteoporosis	6.22e-05	0.000243	CcSEcCtD
Doxorubicin—Diarrhoea—Risedronate—osteoporosis	6.2e-05	0.000242	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	6.2e-05	0.000242	CcSEcCtD
Doxorubicin—Dry mouth—Estradiol—osteoporosis	6.19e-05	0.000242	CcSEcCtD
Doxorubicin—Asthenia—Pamidronate—osteoporosis	6.18e-05	0.000242	CcSEcCtD
Doxorubicin—Dizziness—Ethinyl Estradiol—osteoporosis	6.15e-05	0.00024	CcSEcCtD
Doxorubicin—Confusional state—Estradiol—osteoporosis	6.12e-05	0.000239	CcSEcCtD
Doxorubicin—Pruritus—Pamidronate—osteoporosis	6.1e-05	0.000238	CcSEcCtD
Doxorubicin—Oedema—Estradiol—osteoporosis	6.07e-05	0.000237	CcSEcCtD
Doxorubicin—Anaphylactic shock—Estradiol—osteoporosis	6.07e-05	0.000237	CcSEcCtD
Doxorubicin—Infection—Estradiol—osteoporosis	6.03e-05	0.000236	CcSEcCtD
Doxorubicin—Urticaria—Conjugated Estrogens—osteoporosis	6.02e-05	0.000235	CcSEcCtD
Doxorubicin—Dizziness—Risedronate—osteoporosis	6e-05	0.000234	CcSEcCtD
Doxorubicin—Abdominal pain—Conjugated Estrogens—osteoporosis	5.99e-05	0.000234	CcSEcCtD
Doxorubicin—Body temperature increased—Conjugated Estrogens—osteoporosis	5.99e-05	0.000234	CcSEcCtD
Doxorubicin—Shock—Estradiol—osteoporosis	5.97e-05	0.000233	CcSEcCtD
Doxorubicin—Nervous system disorder—Estradiol—osteoporosis	5.95e-05	0.000232	CcSEcCtD
Doxorubicin—Tachycardia—Estradiol—osteoporosis	5.92e-05	0.000231	CcSEcCtD
Doxorubicin—Vomiting—Ethinyl Estradiol—osteoporosis	5.91e-05	0.000231	CcSEcCtD
Doxorubicin—Diarrhoea—Pamidronate—osteoporosis	5.9e-05	0.00023	CcSEcCtD
Doxorubicin—Skin disorder—Estradiol—osteoporosis	5.89e-05	0.00023	CcSEcCtD
Doxorubicin—Hyperhidrosis—Estradiol—osteoporosis	5.86e-05	0.000229	CcSEcCtD
Doxorubicin—Rash—Ethinyl Estradiol—osteoporosis	5.86e-05	0.000229	CcSEcCtD
Doxorubicin—Dermatitis—Ethinyl Estradiol—osteoporosis	5.86e-05	0.000229	CcSEcCtD
Doxorubicin—Headache—Ethinyl Estradiol—osteoporosis	5.83e-05	0.000228	CcSEcCtD
Doxorubicin—Hypersensitivity—Zoledronate—osteoporosis	5.8e-05	0.000227	CcSEcCtD
Doxorubicin—Vomiting—Risedronate—osteoporosis	5.76e-05	0.000225	CcSEcCtD
Doxorubicin—Rash—Risedronate—osteoporosis	5.72e-05	0.000223	CcSEcCtD
Doxorubicin—Dermatitis—Risedronate—osteoporosis	5.71e-05	0.000223	CcSEcCtD
Doxorubicin—Dizziness—Pamidronate—osteoporosis	5.7e-05	0.000223	CcSEcCtD
Doxorubicin—Headache—Risedronate—osteoporosis	5.68e-05	0.000222	CcSEcCtD
Doxorubicin—Asthenia—Zoledronate—osteoporosis	5.65e-05	0.000221	CcSEcCtD
Doxorubicin—Hypersensitivity—Conjugated Estrogens—osteoporosis	5.58e-05	0.000218	CcSEcCtD
Doxorubicin—Pruritus—Zoledronate—osteoporosis	5.57e-05	0.000218	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Estradiol—osteoporosis	5.53e-05	0.000216	CcSEcCtD
Doxorubicin—Nausea—Ethinyl Estradiol—osteoporosis	5.52e-05	0.000216	CcSEcCtD
Doxorubicin—Insomnia—Estradiol—osteoporosis	5.49e-05	0.000214	CcSEcCtD
Doxorubicin—Vomiting—Pamidronate—osteoporosis	5.48e-05	0.000214	CcSEcCtD
Doxorubicin—Paraesthesia—Estradiol—osteoporosis	5.45e-05	0.000213	CcSEcCtD
Doxorubicin—Asthenia—Conjugated Estrogens—osteoporosis	5.44e-05	0.000213	CcSEcCtD
Doxorubicin—Rash—Pamidronate—osteoporosis	5.43e-05	0.000212	CcSEcCtD
Doxorubicin—Dermatitis—Pamidronate—osteoporosis	5.43e-05	0.000212	CcSEcCtD
Doxorubicin—Dyspnoea—Estradiol—osteoporosis	5.41e-05	0.000211	CcSEcCtD
Doxorubicin—Headache—Pamidronate—osteoporosis	5.4e-05	0.000211	CcSEcCtD
Doxorubicin—Somnolence—Estradiol—osteoporosis	5.39e-05	0.000211	CcSEcCtD
Doxorubicin—Diarrhoea—Zoledronate—osteoporosis	5.39e-05	0.00021	CcSEcCtD
Doxorubicin—Nausea—Risedronate—osteoporosis	5.39e-05	0.00021	CcSEcCtD
Doxorubicin—Pruritus—Conjugated Estrogens—osteoporosis	5.36e-05	0.00021	CcSEcCtD
Doxorubicin—Dyspepsia—Estradiol—osteoporosis	5.34e-05	0.000209	CcSEcCtD
Doxorubicin—Decreased appetite—Estradiol—osteoporosis	5.27e-05	0.000206	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Estradiol—osteoporosis	5.24e-05	0.000205	CcSEcCtD
Doxorubicin—Fatigue—Estradiol—osteoporosis	5.23e-05	0.000204	CcSEcCtD
Doxorubicin—Dizziness—Zoledronate—osteoporosis	5.21e-05	0.000203	CcSEcCtD
Doxorubicin—Pain—Estradiol—osteoporosis	5.19e-05	0.000203	CcSEcCtD
Doxorubicin—Constipation—Estradiol—osteoporosis	5.19e-05	0.000203	CcSEcCtD
Doxorubicin—Diarrhoea—Conjugated Estrogens—osteoporosis	5.19e-05	0.000203	CcSEcCtD
Doxorubicin—Nausea—Pamidronate—osteoporosis	5.12e-05	0.0002	CcSEcCtD
Doxorubicin—TOP2A—Levonorgestrel—Ethinyl Estradiol—osteoporosis	5.06e-05	0.012	CbGdCrCtD
Doxorubicin—Dizziness—Conjugated Estrogens—osteoporosis	5.01e-05	0.000196	CcSEcCtD
Doxorubicin—Vomiting—Zoledronate—osteoporosis	5.01e-05	0.000196	CcSEcCtD
Doxorubicin—Feeling abnormal—Estradiol—osteoporosis	5e-05	0.000195	CcSEcCtD
Doxorubicin—Rash—Zoledronate—osteoporosis	4.96e-05	0.000194	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Estradiol—osteoporosis	4.96e-05	0.000194	CcSEcCtD
Doxorubicin—Dermatitis—Zoledronate—osteoporosis	4.96e-05	0.000194	CcSEcCtD
Doxorubicin—Headache—Zoledronate—osteoporosis	4.93e-05	0.000193	CcSEcCtD
Doxorubicin—Vomiting—Conjugated Estrogens—osteoporosis	4.82e-05	0.000188	CcSEcCtD
Doxorubicin—Urticaria—Estradiol—osteoporosis	4.82e-05	0.000188	CcSEcCtD
Doxorubicin—Abdominal pain—Estradiol—osteoporosis	4.8e-05	0.000187	CcSEcCtD
Doxorubicin—Body temperature increased—Estradiol—osteoporosis	4.8e-05	0.000187	CcSEcCtD
Doxorubicin—Rash—Conjugated Estrogens—osteoporosis	4.78e-05	0.000187	CcSEcCtD
Doxorubicin—Dermatitis—Conjugated Estrogens—osteoporosis	4.77e-05	0.000187	CcSEcCtD
Doxorubicin—Headache—Conjugated Estrogens—osteoporosis	4.75e-05	0.000186	CcSEcCtD
Doxorubicin—Nausea—Zoledronate—osteoporosis	4.68e-05	0.000183	CcSEcCtD
Doxorubicin—Nausea—Conjugated Estrogens—osteoporosis	4.5e-05	0.000176	CcSEcCtD
Doxorubicin—Hypersensitivity—Estradiol—osteoporosis	4.47e-05	0.000175	CcSEcCtD
Doxorubicin—Asthenia—Estradiol—osteoporosis	4.35e-05	0.00017	CcSEcCtD
Doxorubicin—Pruritus—Estradiol—osteoporosis	4.29e-05	0.000168	CcSEcCtD
Doxorubicin—Diarrhoea—Estradiol—osteoporosis	4.15e-05	0.000162	CcSEcCtD
Doxorubicin—Dizziness—Estradiol—osteoporosis	4.01e-05	0.000157	CcSEcCtD
Doxorubicin—Vomiting—Estradiol—osteoporosis	3.86e-05	0.000151	CcSEcCtD
Doxorubicin—Rash—Estradiol—osteoporosis	3.83e-05	0.000149	CcSEcCtD
Doxorubicin—Dermatitis—Estradiol—osteoporosis	3.82e-05	0.000149	CcSEcCtD
Doxorubicin—Headache—Estradiol—osteoporosis	3.8e-05	0.000149	CcSEcCtD
Doxorubicin—Nausea—Estradiol—osteoporosis	3.6e-05	0.000141	CcSEcCtD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.75e-05	0.000127	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—TPI1—osteoporosis	1.75e-05	0.000127	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6R—osteoporosis	1.75e-05	0.000127	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.75e-05	0.000126	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.74e-05	0.000126	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IGF1—osteoporosis	1.73e-05	0.000125	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KL—osteoporosis	1.72e-05	0.000125	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PSMA5—osteoporosis	1.72e-05	0.000125	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PSMA2—osteoporosis	1.72e-05	0.000125	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.72e-05	0.000125	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—osteoporosis	1.71e-05	0.000124	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGA—osteoporosis	1.71e-05	0.000124	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYP27A1—osteoporosis	1.71e-05	0.000123	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—MYC—osteoporosis	1.7e-05	0.000123	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ENO1—osteoporosis	1.7e-05	0.000123	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TPI1—osteoporosis	1.7e-05	0.000123	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IRS2—osteoporosis	1.69e-05	0.000122	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ADCY5—osteoporosis	1.67e-05	0.000121	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CYP19A1—osteoporosis	1.67e-05	0.000121	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PSMA5—osteoporosis	1.67e-05	0.000121	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PSMA2—osteoporosis	1.67e-05	0.000121	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GPX1—osteoporosis	1.67e-05	0.000121	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ACP5—osteoporosis	1.66e-05	0.00012	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—P4HB—osteoporosis	1.65e-05	0.000119	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ADCY5—osteoporosis	1.63e-05	0.000118	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ENO1—osteoporosis	1.63e-05	0.000118	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GAPDH—osteoporosis	1.62e-05	0.000117	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ADCY5—osteoporosis	1.62e-05	0.000117	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GPX1—osteoporosis	1.61e-05	0.000117	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PKM—osteoporosis	1.61e-05	0.000116	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—FDPS—osteoporosis	1.61e-05	0.000116	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CALCA—osteoporosis	1.61e-05	0.000116	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—OXCT1—osteoporosis	1.6e-05	0.000116	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CA2—osteoporosis	1.6e-05	0.000116	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—POMC—osteoporosis	1.6e-05	0.000116	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IRS1—osteoporosis	1.6e-05	0.000116	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PSMA5—osteoporosis	1.6e-05	0.000116	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PSMA2—osteoporosis	1.6e-05	0.000116	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—P4HB—osteoporosis	1.59e-05	0.000115	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—RAP1A—osteoporosis	1.58e-05	0.000114	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GAPDH—osteoporosis	1.56e-05	0.000113	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MGLL—osteoporosis	1.56e-05	0.000113	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.56e-05	0.000113	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TPI1—osteoporosis	1.54e-05	0.000112	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—MTHFR—osteoporosis	1.54e-05	0.000112	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—RAP1A—osteoporosis	1.52e-05	0.00011	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PGLS—osteoporosis	1.52e-05	0.00011	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GPD2—osteoporosis	1.52e-05	0.00011	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ENO1—osteoporosis	1.52e-05	0.00011	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—FDPS—osteoporosis	1.51e-05	0.00011	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PKM—osteoporosis	1.51e-05	0.00011	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6R—osteoporosis	1.51e-05	0.000109	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.51e-05	0.000109	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ADCY5—osteoporosis	1.5e-05	0.000109	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MTHFR—osteoporosis	1.5e-05	0.000109	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PSMA2—osteoporosis	1.5e-05	0.000109	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PSMA5—osteoporosis	1.5e-05	0.000109	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GPX1—osteoporosis	1.5e-05	0.000108	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—MTHFR—osteoporosis	1.49e-05	0.000108	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IRS1—osteoporosis	1.47e-05	0.000107	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KL—osteoporosis	1.46e-05	0.000106	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—P4HB—osteoporosis	1.45e-05	0.000105	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PGLS—osteoporosis	1.43e-05	0.000104	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GPD2—osteoporosis	1.43e-05	0.000104	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TGFB1—osteoporosis	1.43e-05	0.000103	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IRS2—osteoporosis	1.43e-05	0.000103	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GAPDH—osteoporosis	1.42e-05	0.000103	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CALCA—osteoporosis	1.4e-05	0.000101	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ATIC—osteoporosis	1.39e-05	0.000101	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PNP—osteoporosis	1.39e-05	0.000101	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—RAP1A—osteoporosis	1.39e-05	0.0001	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6R—osteoporosis	1.38e-05	0.0001	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—MTHFR—osteoporosis	1.38e-05	0.0001	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.37e-05	9.95e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ADCY5—osteoporosis	1.37e-05	9.89e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GPX1—osteoporosis	1.36e-05	9.85e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CYP19A1—osteoporosis	1.36e-05	9.81e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ADCY5—osteoporosis	1.35e-05	9.78e-05	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—MYC—osteoporosis	1.33e-05	9.63e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—IDH2—osteoporosis	1.33e-05	9.63e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.33e-05	9.62e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ATIC—osteoporosis	1.31e-05	9.5e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PNP—osteoporosis	1.31e-05	9.5e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SPP1—osteoporosis	1.31e-05	9.46e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CYP19A1—osteoporosis	1.3e-05	9.41e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ENO1—osteoporosis	1.27e-05	9.22e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KL—osteoporosis	1.27e-05	9.18e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—MTHFR—osteoporosis	1.26e-05	9.09e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PSMA5—osteoporosis	1.26e-05	9.09e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PSMA2—osteoporosis	1.26e-05	9.09e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP27A1—osteoporosis	1.25e-05	9.05e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IRS1—osteoporosis	1.25e-05	9.02e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—POMC—osteoporosis	1.23e-05	8.92e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ENO1—osteoporosis	1.23e-05	8.92e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ACP5—osteoporosis	1.22e-05	8.81e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PSMA2—osteoporosis	1.21e-05	8.79e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PSMA5—osteoporosis	1.21e-05	8.79e-05	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—MYC—osteoporosis	1.19e-05	8.61e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—POMC—osteoporosis	1.19e-05	8.61e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—OXCT1—osteoporosis	1.18e-05	8.57e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CA2—osteoporosis	1.18e-05	8.57e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MYC—osteoporosis	1.18e-05	8.57e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IRS2—osteoporosis	1.18e-05	8.56e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TGFB1—osteoporosis	1.18e-05	8.55e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6R—osteoporosis	1.17e-05	8.47e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—LEP—osteoporosis	1.16e-05	8.38e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MGLL—osteoporosis	1.15e-05	8.35e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ADCY5—osteoporosis	1.14e-05	8.27e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TPI1—osteoporosis	1.13e-05	8.19e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ENO1—osteoporosis	1.12e-05	8.11e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CA2—osteoporosis	1.12e-05	8.08e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—OXCT1—osteoporosis	1.12e-05	8.08e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ADCY5—osteoporosis	1.11e-05	8.02e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—POMC—osteoporosis	1.1e-05	8e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ESR1—osteoporosis	1.1e-05	8e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SPP1—osteoporosis	1.1e-05	8e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PSMA2—osteoporosis	1.1e-05	8e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PSMA5—osteoporosis	1.1e-05	8e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GPX1—osteoporosis	1.1e-05	7.99e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MGLL—osteoporosis	1.09e-05	7.87e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—P4HB—osteoporosis	1.06e-05	7.7e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ADCY5—osteoporosis	1.06e-05	7.69e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GPX1—osteoporosis	1.06e-05	7.66e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—POMC—osteoporosis	1.05e-05	7.59e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GAPDH—osteoporosis	1.04e-05	7.56e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MYC—osteoporosis	1.04e-05	7.51e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TGFB1—osteoporosis	1.03e-05	7.49e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IRS1—osteoporosis	1.03e-05	7.47e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MTHFR—osteoporosis	1.02e-05	7.37e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CYP19A1—osteoporosis	1.02e-05	7.37e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—RAP1A—osteoporosis	1.02e-05	7.36e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—POMC—osteoporosis	1e-05	7.27e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IRS2—osteoporosis	9.99e-06	7.23e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—POMC—osteoporosis	9.94e-06	7.2e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ADCY5—osteoporosis	9.93e-06	7.19e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—FDPS—osteoporosis	9.89e-06	7.16e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PKM—osteoporosis	9.89e-06	7.16e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CYP19A1—osteoporosis	9.85e-06	7.13e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—IDH2—osteoporosis	9.81e-06	7.1e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—LEP—osteoporosis	9.78e-06	7.08e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MTHFR—osteoporosis	9.77e-06	7.07e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6R—osteoporosis	9.7e-06	7.02e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IGF1—osteoporosis	9.56e-06	6.92e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PGLS—osteoporosis	9.38e-06	6.79e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPD2—osteoporosis	9.38e-06	6.79e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ESR1—osteoporosis	9.33e-06	6.76e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—IDH2—osteoporosis	9.24e-06	6.69e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP27A1—osteoporosis	9.22e-06	6.68e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTHFR—osteoporosis	9.14e-06	6.62e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.05e-06	6.55e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.03e-06	6.54e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ACP5—osteoporosis	8.97e-06	6.49e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYP19A1—osteoporosis	8.96e-06	6.49e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MYC—osteoporosis	8.93e-06	6.46e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFB1—osteoporosis	8.91e-06	6.45e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—osteoporosis	8.9e-06	6.44e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IRS1—osteoporosis	8.72e-06	6.31e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IRS2—osteoporosis	8.69e-06	6.29e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP27A1—osteoporosis	8.69e-06	6.29e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PNP—osteoporosis	8.58e-06	6.21e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ATIC—osteoporosis	8.58e-06	6.21e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ACP5—osteoporosis	8.45e-06	6.12e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.45e-06	6.12e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.43e-06	6.1e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—POMC—osteoporosis	8.4e-06	6.08e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TPI1—osteoporosis	8.34e-06	6.04e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ADCY5—osteoporosis	8.32e-06	6.02e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GPX1—osteoporosis	8.29e-06	6e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ENO1—osteoporosis	8.22e-06	5.95e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MYC—osteoporosis	8.2e-06	5.94e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6R—osteoporosis	8.19e-06	5.93e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFB1—osteoporosis	8.18e-06	5.93e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—POMC—osteoporosis	8.15e-06	5.9e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PSMA5—osteoporosis	8.1e-06	5.86e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PSMA2—osteoporosis	8.1e-06	5.86e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IGF1—osteoporosis	8.08e-06	5.85e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ADCY5—osteoporosis	8.05e-06	5.83e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GPX1—osteoporosis	8.02e-06	5.81e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TPI1—osteoporosis	7.86e-06	5.69e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—P4HB—osteoporosis	7.84e-06	5.68e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—POMC—osteoporosis	7.81e-06	5.65e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6—osteoporosis	7.79e-06	5.64e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GAPDH—osteoporosis	7.7e-06	5.57e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MTHFR—osteoporosis	7.65e-06	5.54e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IRS1—osteoporosis	7.59e-06	5.49e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—RAP1A—osteoporosis	7.5e-06	5.43e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MTHFR—osteoporosis	7.4e-06	5.36e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—P4HB—osteoporosis	7.39e-06	5.35e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ADCY5—osteoporosis	7.32e-06	5.3e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GPX1—osteoporosis	7.3e-06	5.28e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CA2—osteoporosis	7.29e-06	5.28e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—OXCT1—osteoporosis	7.29e-06	5.28e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GAPDH—osteoporosis	7.25e-06	5.25e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6R—osteoporosis	7.13e-06	5.16e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MGLL—osteoporosis	7.11e-06	5.15e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—RAP1A—osteoporosis	7.06e-06	5.11e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MYC—osteoporosis	6.93e-06	5.02e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFB1—osteoporosis	6.92e-06	5.01e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MTHFR—osteoporosis	6.73e-06	4.87e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—osteoporosis	6.71e-06	4.86e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP19A1—osteoporosis	6.57e-06	4.76e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—osteoporosis	6.17e-06	4.46e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—POMC—osteoporosis	6.12e-06	4.43e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ENO1—osteoporosis	6.06e-06	4.39e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—IDH2—osteoporosis	6.04e-06	4.38e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PSMA5—osteoporosis	5.97e-06	4.32e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PSMA2—osteoporosis	5.97e-06	4.32e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—POMC—osteoporosis	5.92e-06	4.29e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYC—osteoporosis	5.75e-06	4.16e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—osteoporosis	5.73e-06	4.15e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ENO1—osteoporosis	5.71e-06	4.13e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.68e-06	4.11e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PSMA2—osteoporosis	5.63e-06	4.07e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PSMA5—osteoporosis	5.63e-06	4.07e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ACP5—osteoporosis	5.53e-06	4e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—POMC—osteoporosis	5.38e-06	3.9e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ADCY5—osteoporosis	5.37e-06	3.89e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GPX1—osteoporosis	5.35e-06	3.87e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—osteoporosis	5.21e-06	3.77e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TPI1—osteoporosis	5.14e-06	3.72e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTHFR—osteoporosis	4.94e-06	3.57e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYC—osteoporosis	4.85e-06	3.51e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP19A1—osteoporosis	4.84e-06	3.51e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—osteoporosis	4.84e-06	3.51e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—P4HB—osteoporosis	4.83e-06	3.5e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GAPDH—osteoporosis	4.74e-06	3.43e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—RAP1A—osteoporosis	4.62e-06	3.34e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP19A1—osteoporosis	4.57e-06	3.31e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—osteoporosis	4.32e-06	3.13e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MYC—osteoporosis	4.22e-06	3.06e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—osteoporosis	4.21e-06	3.05e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ADCY5—osteoporosis	3.96e-06	2.87e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—POMC—osteoporosis	3.95e-06	2.86e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GPX1—osteoporosis	3.94e-06	2.86e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ENO1—osteoporosis	3.73e-06	2.7e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADCY5—osteoporosis	3.73e-06	2.7e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GPX1—osteoporosis	3.72e-06	2.69e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PSMA5—osteoporosis	3.68e-06	2.66e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PSMA2—osteoporosis	3.68e-06	2.66e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—osteoporosis	3.65e-06	2.64e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTHFR—osteoporosis	3.64e-06	2.64e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTHFR—osteoporosis	3.43e-06	2.48e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—osteoporosis	3.18e-06	2.3e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.98e-06	2.16e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—POMC—osteoporosis	2.91e-06	2.11e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—POMC—osteoporosis	2.74e-06	1.99e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADCY5—osteoporosis	2.44e-06	1.77e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX1—osteoporosis	2.43e-06	1.76e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTHFR—osteoporosis	2.24e-06	1.62e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—POMC—osteoporosis	1.79e-06	1.3e-05	CbGpPWpGaD
